Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-22

FDA Approved: LUPRON DEPOT-PED — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LUPRON DEPOT-PED (Leuprolide acetate) from AbbVie Inc., supporting its pediatric use. This represents a suppleme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUPRON DEPOT-PED (Leuprolide acetate)

Snippet

SUPPL AP for LUPRON DEPOT-PED (LEUPROLIDE ACETATE)